Thyrotropin Receptor/Thyroglobulin Messenger Ribonucleic Acid in Peripheral Blood and Fine-Needle Aspiration Cytology: Diagnostic Synergy for Detecting Thyroid Cancer
- 1 April 2005
- journal article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (4) , 1921-1924
- https://doi.org/10.1210/jc.2004-1793
Abstract
RT-PCR for thyroglobulin (Tg) and TSH receptor (TSHR) mRNA has been used to detect circulating thyroid cancer cells. Little is known, however, regarding the preoperative sensitivity of this test to detect cancer. Seventy-two patients with thyroid disease (36 with malignancy and 36 with benign disease) were evaluated preoperatively. TSHR and Tg mRNA transcripts were detected by RT-PCR assays, previously determined to be specific for cancer cells. There was 100% concordance between TSHR and Tg mRNA RT-PCR results. Of 36 cancer patients, 11 had recurrent disease, and all were positive by RT-PCR. Among 25 patients with no prior thyroid surgery, 18 tested positive preoperatively (sensitivity 72%). Seven of 36 patients with benign disease tested positive (specificity 80%). The overall preoperative diagnostic accuracy was 77%. Preoperative fine-needle aspiration (FNA) biopsy was performed on 46 of 61 patients with no prior thyroid surgery. FNA was diagnostic in 28 (61%) patients. Preoperative cytology was adequate but not diagnostic in 18 (39%) patients. RT-PCR correctly classified 14 of these 18 patients with indeterminate FNA, and the test detected three of four cancer patients as positive (75% sensitive) and 11 of 14 patients (78% specific) with benign disease as negative. The combined diagnostic performance characteristics for RT-PCR and FNA cytology were sensitivity = 95%, specificity = 83%, and diagnostic accuracy = 89%, with positive and negative predictive values of 84 and 95%, respectively. Our results suggest that the molecular detection of circulating thyroid cancer cells by RT-PCR for TSHR/Tg mRNA complements FNA cytology in the preoperative differentiation of benign from malignant thyroid disease and their combined use may save unnecessary surgeries.Keywords
This publication has 18 references indexed in Scilit:
- Specific Pattern of RAS Oncogene Mutations in Follicular Thyroid TumorsJournal of Clinical Endocrinology & Metabolism, 2003
- Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancerMolecular Pathology, 2003
- RASPoint Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular CarcinomaJournal of Clinical Endocrinology & Metabolism, 2003
- Determination of Galectin-3 Messenger Ribonucleic Acid Overexpression in Papillary Thyroid Cancer by Quantitative Reverse Transcription-Polymerase Chain ReactionJournal of Clinical Endocrinology & Metabolism, 2002
- Galectin-3 Messenger Ribonucleic Acid and Protein Are Expressed in Benign Thyroid TumorsJournal of Clinical Endocrinology & Metabolism, 2002
- Highly Sensitive Serum Thyroglobulin and Circulating Thyroglobulin mRNA Evaluations in the Management of Patients with Differentiated Thyroid Cancer in Apparent RemissionJournal of Clinical Endocrinology & Metabolism, 2002
- Analysis of Tg Transcripts by Real-Time RT-PCR in the Blood of Thyroid Cancer PatientsJournal of Clinical Endocrinology & Metabolism, 2002
- Cytokeratin 19 Immunoreactivity in the Diagnosis of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2001
- Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic typeCancer, 2001
- Diagnostic pitfalls in thyroid fine‐needle aspiration: A review of 394 casesDiagnostic Cytopathology, 1993